These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 17193953)

  • 1. [Recent advances in the medical treatment of glioma-temozolomide].
    Nishikawa R
    No To Shinkei; 2006 Dec; 58(12):1035-41. PubMed ID: 17193953
    [No Abstract]   [Full Text] [Related]  

  • 2. Temozolomide for malignant brain tumours.
    Batchelor T
    Lancet; 2000 Apr; 355(9210):1115-6. PubMed ID: 10791369
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens: is the survival really so impressive?: in regard to Combs et al. (Int J Radiat Oncol Biol Phys 2008;71:999-1005).
    Jalali R
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1622; author reply 1622-3. PubMed ID: 19028293
    [No Abstract]   [Full Text] [Related]  

  • 4. [Temozolomide in patients with a glioblastoma multiforme: new developments].
    Bromberg JE; Postma TJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1376-8. PubMed ID: 15997689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temozolomide in second-line treatment after prior nitrosurea-based chemotherapy in glioblastoma multiforme: experience from a Portuguese institution.
    Teixeira MM; Garcia I; Portela I; Cernuda M; Oliveira C; Albano J; Lima L
    Int J Clin Pharmacol Res; 2002; 22(1):19-22. PubMed ID: 12395915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers.
    Stupp R; Hottinger AF; van den Bent MJ; Dietrich PY; Brandes AA
    Ann Oncol; 2008 Sep; 19 Suppl 7():vii209-16. PubMed ID: 18790951
    [No Abstract]   [Full Text] [Related]  

  • 7. Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy.
    Charnley N; West CM; Barnett CM; Brock C; Bydder GM; Glaser M; Newlands ES; Swindell R; Matthews J; Price P
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):331-8. PubMed ID: 16839701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study.
    Combs SE; Gutwein S; Schulz-Ertner D; van Kampen M; Thilmann C; Edler L; Wannenmacher MM; Debus J
    Strahlenther Onkol; 2005 Jun; 181(6):372-7. PubMed ID: 15925979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic radiotherapy for glioblastoma in the elderly.
    Tartarone A; Ardito R; Romano C
    N Engl J Med; 2007 Jul; 357(2):196; author reply 196. PubMed ID: 17626310
    [No Abstract]   [Full Text] [Related]  

  • 10. Adding concomitant and adjuvant temozolomide to radiotherapy does not reduce health-related quality of life in people with glioblastoma.
    Hamilton DA
    Cancer Treat Rev; 2006 Oct; 32(6):483-6. PubMed ID: 16730911
    [No Abstract]   [Full Text] [Related]  

  • 11. Temozolomide for pediatric high-grade gliomas.
    Packer RJ
    Curr Neurol Neurosci Rep; 2012 Apr; 12(2):111-3. PubMed ID: 22249491
    [No Abstract]   [Full Text] [Related]  

  • 12. Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children.
    Broniscer A; Chintagumpala M; Fouladi M; Krasin MJ; Kocak M; Bowers DC; Iacono LC; Merchant TE; Stewart CF; Houghton PJ; Kun LE; Ledet D; Gajjar A
    J Neurooncol; 2006 Feb; 76(3):313-9. PubMed ID: 16200343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant temozolomide: how long and how much?
    Franceschi E; Tosoni A; Brandes AA
    Expert Rev Anticancer Ther; 2008 May; 8(5):663-5. PubMed ID: 18471038
    [No Abstract]   [Full Text] [Related]  

  • 14. Spanish co-operative group of Medical Neuro-oncology (GENOM).
    Contreras Martínez J; Azcoaga Blasco JM; Delgado Rico R; Wals Zurita A; Villanueva Alvarez A; Rivas Sánchez D; Herruzo Cabrera I
    Clin Transl Oncol; 2006 Oct; 8(10):770. PubMed ID: 17074680
    [No Abstract]   [Full Text] [Related]  

  • 15. Promises and controversies in the management of low-grade glioma.
    Stupp R; Baumert BG
    Ann Oncol; 2003 Dec; 14(12):1695-6. PubMed ID: 14630671
    [No Abstract]   [Full Text] [Related]  

  • 16. Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas.
    Chamberlain MC
    Expert Rev Neurother; 2010 Oct; 10(10):1537-44. PubMed ID: 20925470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme.
    Athanassiou H; Synodinou M; Maragoudakis E; Paraskevaidis M; Verigos C; Misailidou D; Antonadou D; Saris G; Beroukas K; Karageorgis P
    J Clin Oncol; 2005 Apr; 23(10):2372-7. PubMed ID: 15800329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial (Lancet Oncol. 2009;10:459-466).
    Linz U
    Cancer; 2010 Apr; 116(8):1844-6. PubMed ID: 20151424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for malignant gliomas.
    Marosi C
    Wien Med Wochenschr; 2006 Jun; 156(11-12):346-50. PubMed ID: 16944366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoradiotherapy in high-grade gliomas.
    Ulutin C
    Tumori; 2007; 93(5):526; author reply 526. PubMed ID: 18038893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.